Borviz 2 mg Injection
Borviz 2 mg Injection contains Bortezomib 2 mg, an anti-cancer medicine used under oncologist supervision for certain blood cancers. It is commonly used in the treatment of multiple myeloma and mantle cell lymphoma.
Bortezomib belongs to a class of medicines known as proteasome inhibitors. It helps stop or slow the growth of cancer cells by interfering with protein breakdown inside cells, which can lead to cancer cell death.
Composition & Product Details
Product Name: Broviz 2 mg Injection
Composition: Bortezomib 2 mg
Medicine Category: Oncology / Anti-Cancer Medicine
Drug Class: Proteasome Inhibitor
Dosage Form: Injection
Strength: 2 mg
Common Use: Multiple myeloma and mantle cell lymphoma
Administration: By qualified healthcare professional only
Supplier/Exporter: Ernest Impex
Clinical Indications & Usage
Borviz 2 mg Injection may be prescribed by oncology specialists for:
- Multiple myeloma
- Mantle cell lymphoma
- Selected hematological malignancies as advised by an oncologist
It is a prescription oncology medicine and should never be used without specialist medical supervision. Product information sources list Borviz 2 mg Injection for multiple myeloma and mantle-cell lymphoma.
How Borviz 2 mg Injection Works
Borviz 2 mg Injection contains Bortezomib, which works by blocking the proteasome system inside cells. The proteasome normally breaks down proteins in cells. When this process is blocked, abnormal proteins build up inside cancer cells, which can lead to cancer cell death.
This targeted mechanism helps slow cancer cell growth and supports oncology treatment plans for selected blood cancers.
Administration and Dosage Guide
Borviz 2 mg Injection should be administered only by a doctor, nurse, or trained oncology healthcare professional. It may be given by intravenous or subcutaneous route, depending on the doctor’s decision.
The dose and schedule depend on:
- Cancer type
- Body surface area
- Patient’s health condition
- Blood test results
- Other medicines being used
- Doctor’s treatment protocol
Do not self-administer this injection.
Safety, Side Effects & Monitoring
Possible side effects may include:
- Fatigue
- Nausea
- Vomiting
- Diarrhea
- Loss of appetite
- Dizziness
- Weakness
- Low platelet count
- Low white blood cell count
- Anemia
- Numbness or tingling
- Infection risk
Borviz 2 mg Injection may reduce blood cell counts, so regular blood tests may be required during treatment.
Precautions
Use Borviz 2 mg Injection carefully in patients with:
- Liver disease
- Kidney disease
- Heart disease
- Bleeding problems
- Low blood counts
- Active infection
- Nerve-related symptoms
- Pregnancy or breastfeeding condition
Bortezomib is not recommended during pregnancy or breastfeeding unless a specialist decides the benefit outweighs risk.
Storage and Handling
General storage guidance:
- Store as per product label instructions
- Keep away from direct sunlight
- Protect from moisture
- Do not freeze unless mentioned on label
- Keep out of reach of children
- Do not use after expiry date
- Do not use if vial is damaged
Some product sources mention storage below 25°C, while other bortezomib product pages mention refrigerated storage for certain variants, so always follow the exact product label.
FAQ
1. What is Borviz 2 mg Injection used for?
Borviz 2 mg Injection is used under oncologist supervision for certain blood cancers, including multiple myeloma and mantle cell lymphoma.
2. What is the composition of Borviz 2 mg Injection?
Borviz 2 mg Injection contains Bortezomib 2 mg.
3. Is Borviz 2 mg Injection an anti-cancer medicine?
Yes. It is an oncology medicine used in selected cancer treatment protocols.
4. How does Borviz 2 mg Injection work?
It works by blocking proteasome activity inside cells, leading to protein build-up and cancer cell death.
5. Can Borviz 2 mg Injection be self-administered?
No. It should be given only by a qualified healthcare professional.
6. Is Borviz 2 mg Injection chemotherapy?
It is an anti-cancer targeted medicine known as a proteasome inhibitor. It is used in oncology treatment plans.
7. What are common side effects of Borviz 2 mg Injection?
Common side effects may include fatigue, nausea, vomiting, diarrhea, weakness, dizziness, low blood counts, and numbness or tingling.
8. Can Borviz 2 mg Injection reduce blood cell counts?
Yes. It may reduce white blood cells, red blood cells, and platelets, so regular blood monitoring may be required.
9. Is Borviz 2 mg Injection safe during pregnancy?
It is generally not recommended during pregnancy unless specifically advised by an oncologist.
10. Can breastfeeding women use Borviz 2 mg Injection?
Breastfeeding women should avoid use unless advised by a specialist, as safety risks may apply.
